e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Lung function tests to monitor airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung function in never smoking patients with alpha1antitrypsin deficiency
R. A. Stockley, R. G. Edgar (Birmingham, United Kingdom)
Source:
Annual Congress 2013 –Lung function tests to monitor airway diseases
Session:
Lung function tests to monitor airway diseases
Session type:
Poster Discussion
Number:
4709
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. A. Stockley, R. G. Edgar (Birmingham, United Kingdom). Lung function in never smoking patients with alpha1antitrypsin deficiency. Eur Respir J 2013; 42: Suppl. 57, 4709
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
The physiology of breathlessness
Related content which might interest you:
Air trapping is associated with exercise capacity in persons without overt obstructive lung disease
Source: International Congress 2016 – Mechanisms of symptoms and exercise limitation in health and disease
Year: 2016
Small airway obstruction involvement in COPD severity
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Proteinase-inhibitor system state in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Antagonism of substance P and perception of dyspnea in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Plasma surfactant protein D (SP-D) and smoking status in patients with COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Change in lung functions in patients with COPD during 6MWT
Source: Annual Congress 2013 –Clinical exercise physiology
Year: 2013
Lung clearance index is increased in patients with COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Heterogeneity inside group D COPD patients: About 827 cases
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Gender differences in COPD patients
Source: International Congress 2014 – Clinical presentations
Year: 2014
The effect of Vitamin D deficiency on lung function in current smoker COPD patients
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014
COPD and lung cancer: Prevalence, infradiagnosis, phenotypes and multidimensional characterization
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
Evaluation of vitamin D levels in COPD and its correlation with disease severity and frequency of exacerbations
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients
Source: International Congress 2016 – Monitoring airway diseases with different tools
Year: 2016
Clinical characteristics, pulmonary function, and response to beta2-agonist: Patients with asthma vs. patients with asthma/COPD overlap syndrome
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013
Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016
Determinants of severity of dyspnea in COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Breathlessness perception in COPD: Relationship with exacerbation frequency
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015
Features of systemic inflammation in patients with stable COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Lung cancer in patient with chronic obstructive pulmonary disease (comorbidity by smokers-a cumulative effect of exogenic and endogenic factors? Part II)
Source: Annual Congress 2013 –COPD treatment
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept